Adagio Medical Holdings, Inc.
Nasdaq · CIK 0002006986 · Fiscal year end 1231
Latest reported period: Latest published period
Revenue
$0
Cost Of Revenue
$253,000
Operating Income
$-5.2M
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $0 | - | - |
| Cost Of Revenue | $253,000 | - | - |
| Operating Income | $-5.2M | - | - |
| Net Income | $-7.0M | - | - |
| Eps Basic | -0.31 | - | - |
| Eps Diluted | -0.31 | - | - |
| Cash And Equivalents | $12.9M | - | - |
| Total Assets | $39.3M | - | - |
| Total Liabilities | $33.6M | - | - |
| Shareholders Equity | $5.7M | - | - |
| Operating Cash Flow | $-4.1M | - | - |
| Capital Expenditures | $2,000 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | Adagio Medical Holdings, Inc. | 2026-05-12 | 0001104659-26-059027 |
| 10-K | Adagio Medical Holdings, Inc. | 2026-03-27 | 0002006986-26-000003 |
| 4 | Adagio Medical Holdings, Inc. | 2025-12-18 | 0002089223-25-000002 |
| 4 | Adagio Medical Holdings, Inc. | 2025-12-15 | 0001964615-25-000003 |
| 10-Q | Adagio Medical Holdings, Inc. | 2025-11-12 | 0001104659-25-110345 |
| 10-Q | Adagio Medical Holdings, Inc. | 2025-08-14 | 0001558370-25-011420 |